This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read InMed Pharmaceuticals’s 8K filing here.
About InMed Pharmaceuticals
InMed Pharmaceuticals Inc, a clinical stage pharmaceutical company, develops a pipeline of prescription-based products. The company operates through two segments, the InMed and the BayMedica. The InMed segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry.
Further Reading
- Five stocks we like better than InMed Pharmaceuticals
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Inflation Risk Rising, Key Trades Investors Are Making Now
- What is the FTSE 100 index?
- 3 Oil Stocks to Watch Before Earnings Come Out
- 3 Warren Buffett Stocks to Buy Now
- Is American Express Stock’s Sell-the-News Reaction a Buying Opp?
